• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名重症骨髓移植受者在同时接受西酞普兰和米氮平治疗后出现与利奈唑胺相关的5-羟色胺综合征。

Linezolid-associated serotonin syndrome after concomitant treatment with citalopram and mirtazepine in a critically ill bone marrow transplant recipient.

作者信息

DeBellis Ronald J, Schaefer Oren P, Liquori Michelina, Volturo Gregory A

机构信息

Massachusetts College of Pharmacy and Health Sciences-Worcester, MA, USA.

出版信息

J Intensive Care Med. 2005 Nov-Dec;20(6):351-3. doi: 10.1177/0885066605280825.

DOI:10.1177/0885066605280825
PMID:16280409
Abstract

Linezolid was initially discovered as an antidepressant because of its effect on blocking intracellular metabolism of serotonin, norepinephrine, and other biogenic amines. As time passed, it was realized that linezolid possessed antibacterial activity, and linezolid has been developed and marketed as such. In medicine we are quick to categorize drugs into specific classes as a mechanism to recall indication and use. By classifying linezolid as an antibacterial, it is common to forget about its antidepressant roots. A case report involving linezolid with citalopram and mirtazepine in the precipitation of serotonin syndrome in a critically ill bone marrow transplant patient is described in this article.

摘要

利奈唑胺最初因其对阻断血清素、去甲肾上腺素和其他生物胺的细胞内代谢的作用而被发现为一种抗抑郁药。随着时间的推移,人们认识到利奈唑胺具有抗菌活性,并以此进行了开发和销售。在医学领域,我们很快就会将药物归类到特定类别,以此作为一种记忆适应证和用法的机制。将利奈唑胺归类为抗菌药物后,人们常常会忘记它的抗抑郁根源。本文描述了一例在重症骨髓移植患者中,利奈唑胺与西酞普兰和米氮平共同引发血清素综合征的病例报告。

相似文献

1
Linezolid-associated serotonin syndrome after concomitant treatment with citalopram and mirtazepine in a critically ill bone marrow transplant recipient.一名重症骨髓移植受者在同时接受西酞普兰和米氮平治疗后出现与利奈唑胺相关的5-羟色胺综合征。
J Intensive Care Med. 2005 Nov-Dec;20(6):351-3. doi: 10.1177/0885066605280825.
2
Serotonin syndrome after concomitant treatment with linezolid and citalopram.利奈唑胺与西酞普兰联合治疗后出现血清素综合征。
Clin Infect Dis. 2003 May 1;36(9):1197. doi: 10.1086/374558. Epub 2003 Apr 21.
3
Serotonin syndrome as a consequence of drug-resistant infections: an interaction between linezolid and citalopram.作为耐药性感染后果的血清素综合征:利奈唑胺与西酞普兰之间的相互作用。
J Am Med Dir Assoc. 2004 Mar-Apr;5(2):111-3. doi: 10.1097/01.JAM.0000110645.20530.46.
4
Myelosuppression and serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients.骨髓移植受者同时使用利奈唑胺和选择性5-羟色胺再摄取抑制剂相关的骨髓抑制和血清素综合征。
Clin Infect Dis. 2003 Jul 1;37(1):e8-11. doi: 10.1086/375689. Epub 2003 Jun 25.
5
Linezolid and serotonin toxicity.
Clin Infect Dis. 2003 Nov 1;37(9):1274-5. doi: 10.1086/378895.
6
Comment on: Serotonin syndrome due to co-administration of linezolid and venlafaxine.关于:联用利奈唑胺和文拉法辛导致血清素综合征的评论。
J Antimicrob Chemother. 2004 Oct;54(4):844-5. doi: 10.1093/jac/dkh404. Epub 2004 Aug 18.
7
Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists.联用利奈唑胺和5-羟色胺激动剂时发生5-羟色胺综合征的风险。
Pharmacotherapy. 2006 Dec;26(12):1784-93. doi: 10.1592/phco.26.12.1784.
8
Serotonin syndrome precipitated by linezolid in a medically ill patient on duloxetine.在服用度洛西汀的内科疾病患者中,由利奈唑胺引发的血清素综合征。
J Clin Psychopharmacol. 2006 Dec;26(6):681-3. doi: 10.1097/01.jcp.0000239793.29449.75.
9
[Serotonergic syndrome in combination of linezolid (Zyvixid) and SSRI].利奈唑胺(斯沃)与选择性5-羟色胺再摄取抑制剂联用所致的5-羟色胺综合征
Lakartidningen. 2009;106(44):2856.
10
Linezolid and serotonin syndrome.利奈唑胺与5-羟色胺综合征
Psychosomatics. 2001 Sep-Oct;42(5):432-4. doi: 10.1176/appi.psy.42.5.432.

引用本文的文献

1
Clinically Relevant Interactions with Anti-Infectives on Intensive Care Units-A Multicenter Delphi Study.重症监护病房中抗感染药物的临床相关相互作用——一项多中心德尔菲研究
Antibiotics (Basel). 2021 Oct 31;10(11):1330. doi: 10.3390/antibiotics10111330.
2
Linezolid-induced serotonin syndrome.利奈唑胺所致血清素综合征。
Ind Psychiatry J. 2020 Jul-Dec;29(2):345-348. doi: 10.4103/ipj.ipj_37_19. Epub 2021 Mar 15.
3
Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques.
与血清素综合征相关的重度动脉高血压的管理:基于系统评价技术的病例报告分析
Ther Adv Psychopharmacol. 2019 Mar 11;9:2045125318818814. doi: 10.1177/2045125318818814. eCollection 2019.
4
Psychotropic drug therapy in patients in the intensive care unit - usage, adverse effects, and drug interactions: a review.重症监护病房患者的精神药物治疗——使用情况、不良反应及药物相互作用:综述
Ther Clin Risk Manag. 2018 Sep 28;14:1799-1812. doi: 10.2147/TCRM.S176079. eCollection 2018.
5
Linezolid-induced serotonin toxicity in a patient not taking monoamine oxidase inhibitors or serotonin receptor antagonists.在一名未服用单胺氧化酶抑制剂或5-羟色胺受体拮抗剂的患者中,利奈唑胺诱发的5-羟色胺毒性反应
Proc (Bayl Univ Med Cent). 2016 Apr;29(2):214-5. doi: 10.1080/08998280.2016.11929423.
6
Linezolid-induced near-fatal serotonin syndrome during escitalopram therapy: case report and review of literature.艾司西酞普兰治疗期间利奈唑胺诱发的近乎致命的血清素综合征:病例报告及文献综述
Indian J Psychol Med. 2013 Oct;35(4):413-6. doi: 10.4103/0253-7176.122245.
7
Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams.抗菌药物药代动力学药物相互作用:对恶唑烷酮类、利福霉素类、大环内酯类、氟喹诺酮类和β-内酰胺类药物的系统评价
Pharmaceutics. 2011 Nov 18;3(4):865-913. doi: 10.3390/pharmaceutics3040865.
8
Linezolid is associated with serotonin syndrome in a patient receiving amitriptyline, and fentanyl: a case report and review of the literature.在一名正在接受阿米替林和芬太尼治疗的患者中,利奈唑胺与5-羟色胺综合征相关:一例病例报告及文献综述。
Case Rep Psychiatry. 2013;2013:617251. doi: 10.1155/2013/617251. Epub 2013 Mar 4.
9
Pharmacological issues of linezolid: an updated critical review.利奈唑胺的药理学问题:更新的批判性评价。
Clin Pharmacokinet. 2010 Jul;49(7):439-47. doi: 10.2165/11319960-000000000-00000.
10
Linezolid and serotonin syndrome.利奈唑胺与5-羟色胺综合征
Prim Care Companion J Clin Psychiatry. 2009;11(6):353-6. doi: 10.4088/PCC.09r00853.